[BREAKING] [Breaking News] The stock is expected to rise in July due to a joint venture between Koreait and Sweden & Germany Bio, a treatment made by Corona Chiroze Development (Hexon Bio and Swalit).

1 June Share

[BREAKING] [Breaking News] The stock is expected to rise in July due to a joint venture between Koreait and Sweden & Germany Bio, a treatment made by Corona Chiroze Development (Hexon Bio and Swalit).

[速報]コロナチロゼ開発(ヘクソンバイオとSWORLit)で作った治療剤「韓国it」とスウェーデン&ドイツバイオの合弁で株式が上がると予想、7月から販売予定だ。

韩国it和瑞典&德国生物公司（hexon bio）在开发新冠病毒治疗剂（hexon bio和swall it）中研制的治疗剂——韩国it和瑞典&德国生物公司的合作下，预计股票将从7月开始销售。

С июля ожидается, что акции вырастут на совместном предприятии Ourit и Swedish & German Vio, разработанном в Coronachirose Development (Гексон Био и Сволт).

[속보] 코로나 치로제 개발 (헥슨바이오와 스월it)에서 만든 치료제 우리나라it와 스웨덴&독일바이오의 합작으로 주식이 올라갈 것으로 예상, 7월부터 판매예정이다. [More News]